Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 4

Status

Completed 7Terminated 4Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 3Gastrointestinal 2

Conditions

Venous Thromboembolism 3Venous Thrombosis 2Pulmonary Embolism 2Thromboembolism 1Pancreatic Neoplasms 1Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 49Radiotherapy 47Docetaxel 42Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Imatinib Mesylate 14Drug Therapy 14Irinotecan 13Filgrastim 13Zoledronic Acid 12Trastuzumab 12Radiosurgery 12Erlotinib Hydrochloride 12Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Dalteparin × Clear all
NCT05171075 2026-04-17

MAGNOLIA

Anthos Therapeutics, Inc.

Phase 3 Terminated
417 enrolled
Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00876915 2015-11-24

PHACS

University of Rochester

Phase 3 Terminated
218 enrolled 20 charts
Classical hematology

Pulmonary Embolism, Venous Thromboembolism

NCT00031837 2015-10-14

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

University of Rochester

Phase 3 Terminated
400 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡